Annual Bayer Pharma Media Day 2022
Not intended for U.S. and UK Media
Berlin, Germany, January 17, 2022 - Bayer will host its annual Pharma Media Day on Monday, February 21st, 14.30h - 17.00h CET. Registration is required to participate and interested media representatives can pre-register under the following link/QR code:
Bayer will showcase the company’s growth potential by continuing to drive innovation across the company’s therapeutic areas and modalities. From diagnosis to treatment to care, the Pharma Media Day 2022 will highlight the latest advancements in radiology, cardiology, oncology, women’s health and sustainability.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.com.
Find more information at https://pharma.bayer.com
Follow us on Facebook: http://www.facebook.com/bayer
Follow us on Twitter: @BayerPharma
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Dr. Nuria Aiguabella Font
Cell and Gene Therapies and New Modalities
+49 30 2215 41582